SEC Form 4 · accession 0001189727-18-000012

ICU MEDICAL INC/DE · ICUI

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Alison D Burcar

Officer — Vice President and Gen'l Mgr.

Period of report

Jun 21, 2018

Accepted (ET)

Jun 21, 2018 · 6:25 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000883984

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock	Jun 21, 2018	X	13,219	$88.76	A	13,219	D
Common Stock	Jun 21, 2018	X	1,976	$58.79	A	15,195	D
Common Stock^F1	Jun 21, 2018	S	3,320	$295.27	D	11,875	D
Common Stock^F2	Jun 21, 2018	S	4,704	$296.34	D	7,171	D
Common Stock^F3	Jun 21, 2018	S	5,502	$297.38	D	1,669	D
Common Stock^F4	Jun 21, 2018	S	1,412	$298.24	D	257	D
Common Stock^F5	Jun 21, 2018	S	257	$301.12	D	0	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Non-Qualified Stock Option (right to buy)^F7,F6	$58.79	Jun 21, 2018	X	1,976	D	—	Feb 24, 2024	Common Stock	1,976	0	D
Non-Qualified Stock Option (right to buy)^F7,F8	$88.76	Jun 21, 2018	X	13,219	D	—	Feb 11, 2025	Common Stock	13,219	0	D

Explanation of responses

F1The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $294.75 to $295.75, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F2The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $295.80 to $296.80, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F3The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $296.85 to $297.85, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F4The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $297.95 to $298.50, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F5The price reported in Column 4 is an average weighted price. These shares were sold in multiple transactions at prices ranging from $301.00 to $302.00, inclusive. The reporting person undertakes to provide ICU Medical, Inc., any security holder of ICU Medical, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
F6Options exercisable in four equal annual cumulative installments commencing one year after the grant date.
F7Transaction is the exercise of a derivative security; see Column 2.
F8Options exercisable one-third annually over the first three anniversaries of the grant date.

Remarks

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2018.